谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Clinical Activity of Target-Preserving Anti-Ctla-4 Antibody ONC-392 As Monotherapy in NSCLC Patients Who Progressed on PD(L)1-targeted Immunotherapy

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 2|浏览34
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要